The Recall Desk

State

Washington product recalls

73,905 recalls have nationwide distribution and so reach Washington. 8,539 additional recalls listed Washington specifically in their distribution scope.

What the numbers show

Total
8,539
Critical
865
Severe
2,407
Most recent
2026-11-11

Of the 8,539 recalls naming Washington we have scored against our rubric, 865 (10%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 2,407 (28%) are Severe.

These figures cover only the 8,539 recalls whose distribution notice names Washington specifically. The 73,905 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.

66976–67000 of 82444

  • SevereFDA (Drugs)·D-1033-2014·2014-01-29

    Hospira Recalls Propofol Vials Due to Glass Particulate Matter

    Hospira is recalling 126,425 vials of Propofol Injectable Emulsion due to a glass defect that could release particulate matter into the solution.

    Product
    PROPOFOL — PROPOFOL (PROPOFOL)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-861-2014·2014-01-29

    Aidapak Recalls Digoxin Tablets Due to Potential Label Mixup

    Aidapak Services is recalling Digoxin tablets because they may have been mislabeled as other medications. The repacked drugs were distributed in four western states.

    Product
    DIGOXIN, Tablet, 0.125 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00115981101.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-903-2014·2014-01-29

    Aidapak Recalls Atorvastatin Calcium Tablets Due to Potential Label Mixup

    Aidapak Services, LLC is recalling 80 mg Atorvastatin Calcium tablets because they may have been mislabeled as other prescription drugs.

    Product
    ATORVASTATIN CALCIUM, Tablet, 80 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378212277.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-982-2014·2014-01-29

    FDA Recalls Mislabeled Acetaminophen, Butalbital, and Caffeine Tablets

    Aidapak Services, LLC is recalling Acetaminophen/Butalbital/Caffeine tablets that may have been mislabeled as Aspirin. The error could cause patients to take the wrong medication.

    Product
    ACETAMINOPHEN/ BUTALBITAL/ CAFFEINE, Tablet, 325 mg/50 mg/40 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00603254421.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-990-2014·2014-01-29

    FDA Recalls Phenobarbital Tablets Due to Potential Pregabalin Labeling Error

    Aidapak Services is recalling Phenobarbital tablets that may be mislabeled as Pregabalin capsules. The error poses a risk of patients receiving the wrong medication.

    Product
    PHENobarbital, Tablet, 64.8 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00603516721.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-897-2014·2014-01-29

    Aidapak Recalls Levothyroxine Sodium Tablets Due to Labeling Errors

    Aidapak Services, LLC is recalling Levothyroxine Sodium 88 mcg tablets because they may have been mislabeled as other prescription drugs.

    Product
    LEVOTHYROXINE SODIUM, Tablet, 88 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378180701.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-975-2014·2014-01-29

    FDA Recalls Mislabeled Quinidine Sulfate Tablets Distributed by Aidapak

    Aidapak Services, LLC is recalling Quinidine Sulfate 200 mg tablets that may have been mislabeled as Quinapril 40 mg. The error occurred during repacking in four western states.

    Product
    quiNIDine SULFATE, Tablet, 200 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591543801.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-873-2014·2014-01-29

    Dutasteride Capsules Recalled for Potential Labeling Mixup

    Aidapak Services is recalling 0.5 mg dutasteride capsules because they may have been mislabeled as phenol, repaglinide, or cholecalciferol.

    Product
    DUTASTERIDE, Capsule, 0.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00173071215.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-820-2014·2014-01-29

    Carbamazepine ER Tablets Recalled for Potential Label Mixup

    Aidapak Services is recalling carbamazepine ER tablets that may be mislabeled as isosorbide dinitrate or sirolimus.

    Product
    carBAMazepine ER, Tablet, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00078051005.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-870-2014·2014-01-29

    Aidapak Recalls Anagrelide HCL Capsules Due to Potential Label Mixup

    Aidapak Services, LLC is recalling Anagrelide HCL capsules because they may have been mislabeled as Aripiprazole tablets.

    Product
    ANAGRELIDE HCL, Capsule, 0.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00172524160.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-898-2014·2014-01-29

    Aidapak Recalls Levothyroxine Sodium Tablets Due to Labeling Errors

    Aidapak Services, LLC is recalling Levothyroxine Sodium 112 mcg tablets because they may have been mislabeled as other drugs. The repacked drugs were distributed in four western states.

    Product
    LEVOTHYROXINE SODIUM, Tablet, 112 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378181101.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-952-2014·2014-01-29

    FDA Recalls Estradiol Tablets Due to Potential Labeling Error

    Aidapak Services, LLC is recalling Estradiol 0.5 mg tablets because they may have been mislabeled as Nicotine Polacrilex gum.

    Product
    ESTRADIOL, Tablet, 0.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00555089902.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-1031-2014·2014-01-29

    KVK-Tech Recalls Hydroxyzine Hydrochloride Tablets Due to Unapproved Ingredient Source

    KVK-Tech, Inc. is recalling 249,096 bottles of Hydroxyzine Hydrochloride tablets because the active pharmaceutical ingredient was sourced from an unapproved supplier.

    Product
    HYDROXYZINE HYDROCHLORIDE — HYDROXYZINE HYDROCHLORIDE (HYDROXYZINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-855-2014·2014-01-29

    FDA Recalls MEXILETINE HCL Capsules Due to Potential Labeling Error

    Aidapak Services, LLC is recalling MEXILETINE HCL capsules because they may have been mislabeled as CALCIUM ACETATE. The error could lead to patients receiving the wrong medication.

    Product
    MEXILETINE HCL, Capsule, 150 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093873901.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-796-2014·2014-01-29

    Buprenorphine HCL Tablets Recalled for Potential Label Mixup

    Aidapak Services, LLC is recalling Buprenorphine HCL SL tablets due to a potential label mixup with other medications.

    Product
    BUPRENORPHINE HCL SL, Tablet, 2 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00054017613.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-765-2014·2014-01-29

    Aidapak Recalls Atomoxetine Capsules Due to Potential Label Mixup

    Aidapak Services is recalling Atomoxetine HCL capsules because they may be mislabeled as other psychiatric medications.

    Product
    ATOMOXETINE HCL, Capsule, 40 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00002322930.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-867-2014·2014-01-29

    Aidapak Recalls Doxycycline Hyclate Capsules Due to Labeling Error

    Aidapak Services, LLC is recalling Doxycycline Hyclate 100 mg capsules because they may have been mislabeled as Raloxifene HCL 60 mg tablets.

    Product
    DOXYCYCLINE HYCLATE, Capsule, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00143314250.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-815-2014·2014-01-29

    FDA Recalls Valsartan Tablets Due to Potential Labeling Mixup

    Aidapak Services, LLC is recalling Valsartan 80 mg tablets because they may have been mislabeled as other prescription drugs.

    Product
    VALSARTAN, Tablet, 80 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00078035834.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-841-2014·2014-01-29

    Simvastatin Tablets Recalled for Potential Labeling Error

    Aidapak Services is recalling Simvastatin 5 mg tablets that may be mislabeled as Losartan Potassium 25 mg.

    Product
    SIMVASTATIN, Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093715298.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-879-2014·2014-01-29

    Aidapak Recalls Lovastatin Tablets Due to Potential Label Mixup

    Aidapak Services, LLC is recalling 20 mg Lovastatin tablets because they may have been mislabeled as other prescription drugs. The repacked drugs were distributed in four western states.

    Product
    LOVASTATIN, Tablet, 20 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00185007201.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-795-2014·2014-01-29

    Aidapak Recalls Acarbose Tablets Due to Potential Labeling Errors

    Aidapak Services, LLC is recalling Acarbose 25 mg tablets because they may be mislabeled as other prescription drugs. The repacked drugs were distributed in four western states.

    Product
    ACARBOSE, Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00054014025.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-993-2014·2014-01-29

    FDA Recalls Propranolol HCL Tablets Due to Potential Label Mixup

    Aidapak Services, LLC is recalling Propranolol HCL 10 mg tablets because they may have been mislabeled as other drugs. The repacked drugs were distributed in four western states.

    Product
    PROPRANOLOL HCL, Tablet, 10 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00603548221.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-892-2014·2014-01-29

    Thioridazine HCL Tablets Recalled for Potential Label Mixup

    Aidapak Services, LLC is recalling Thioridazine HCL 50 mg tablets because they may have been mislabeled as Guanfacine HCl 1 mg tablets.

    Product
    THIORIDAZINE HCL, Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378061601.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-960-2014·2014-01-29

    Aidapak Recalls Lorazepam Tablets Due to Potential Label Mixup

    Aidapak Services, LLC is recalling Lorazepam tablets that may have been mislabeled as Tramadol HCl. The repacked drugs were distributed in four western states.

    Product
    LORazepam, Tablet, 0.25 mg (1/2 of 0.5 mg), Rx only, Distributed by: AidaPak Service, LLC, NDC 00591024001.
    Category
    Drug
    Distribution
    4 states